Spironolactone-associated cutaneous effects: a case report and a review of the literature.
Spironolactone therapy is uncommonly associated with cutaneous side effects. We describe a patient who developed a maculopapular eruption while on spironolactone with a positive reaction upon rechallenge with the drug. The cutaneous associations of spironolactone in the English literature have been reviewed.
Gupta
A K
AK
Division of Dermatology, Sunnybrook Health Science Center, Toronto, Canada.
Knowles
S R
SR
Shear
N H
NH
D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006229:Hand Dermatoses / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced; D012867:Skin / Q000187:drug effects*; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced*; D013148:Spironolactone / Q000009:adverse effects*
D013148:Spironolactone